I am a LT shareholder and I would have to disagree with the statement "nothing has changed fundamentally"
Not so long ago, we had 4 potentially game changing trial results to look forward to this year (3 of them huge).
Fast forward to now, of the 3 trial results, GvHD was not passed and most likely won't be, CHF failed primary end point (but did show improvement in an important endpoint of 60% in mortality rate), COVID ARDS for all intents and purposes indicates a fail.
We have one result remaining.
You must admit that our prospects don't look anywhere near as promising as they did even a week ago.
The one positive is the 60% improvement in mortality rate for CHF. I think this result is too significant to be ignored.
We will have to see how this one plays out.
I would also feel a lot more comfortable if our partner sicks around over the next few days to get us past that 30 day option.
Best wishes to All.
I am a LT shareholder and I would have to disagree with the...
-
- There are more pages in this discussion • 568 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 43856 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 66000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |